A new law is expected to boost medical research in the Philippines, potentially opening doors to greater private sector involvement in the health services industry.
On May 7 President Benigno Aquino ratified legislation passed by the parliament earlier this year that formalises the Philippine National Health Research System (PNHRS) and establishes the Philippine National Health Research Fund.
The PNHRS’s main role will be to set policies and directions, periodically review and approve long-term plans and programmes, and evaluate and approve the national health research agenda. The PNHRS will be governed by a council headed by the secretary of science and technology and the secretary of health, with representatives from the Commission on Higher Education, the chancellor of the University of the Philippines-Manila, the executive director of the National Nutrition Council, the director of the Philippine Council for Health Research and Development, as well as five representatives from the private sector.
The PNHRS itself is not new, although formalising its status and funding marks a policy change. The programme was initially set out in the middle of the past decade to finance the training of more health scientists and provide the necessary resources for undertaking research aligned with the government’s health strategies. Among the key agencies involved in the scheme are the Department of Health; the Philippine Council for Health Research and Development (PCHRD), an agency under the Department of Science and Technology that serves as the national coordinating body for health research; and the Commission on Higher Education.
Research and development work to be conducted within the remit of the PNHRS will in part be financed by the higher taxes on cigarettes and alcohol that went into effect on January 1. The price of cigarettes is expected to double by 2017, while the cost of a bottle of beer is will rise by P23.50 ($0.56). The PCHRD will receive 10% of the revenues collected, which will then be used to fund the PNHRS.
This would represent a significant financial boost to health research, as official estimates put the earnings from the so-called sin tax at $800m for 2013, thus potentially channelling $80m into the system this year alone.
According to Juan Edgardo Angara, a representative in parliament and one of the authors of the PNHRS bill, the programme will provide a framework to strengthen cooperation among the various stakeholders in health research, including private sector players.
“The country must provide for a favourable research environment wherein government agencies, non-government organisations, public and private hospitals, academic institutions and private agencies can optimise their research activities,” Angara said.
The Aquino administration has already been pushing to encourage greater private sector involvement in the health care industry. Through its public-private partnership programme, the government has partially corporatised some hospitals and health centres, opening them up to private investment and management. With the PNHRS fully operational, there will likely be greater support for private research projects, which could benefit such segments of the economy as the pharmaceutical sector, with the $14bn industry currently growing at a rate of between 3% and 4% each year.
Even with additional funding and a structure to steer and monitor health research activities, it will take time for the Philippines to address structural weaknesses. At present, the country is lagging in most international assessments of research support. Spending on research is around 0.03% of national health expenditure, well short of the 2% recommended by the World Health Organisation. Total outlays on research and development in all fields, not just health, account for just over 0.1% of GDP, according to the World Bank, compared to Singapore’s 2.37%.
By building capacity for research and development, the PNHRS will help fuel the innovation that could ultimately improve the health of the nation.
Stay updated on how some of the world’s most promising markets are being affected by the Covid-19 pandemic, and what actions governments and private businesses are taking to mitigate challenges and ensure their long-term growth story continues.
Register now and also receive a complimentary 2-month licence to the OBG Research Terminal.
Register Here×Philippine Airlines has called for the elimination of all government airline subsidies as a pre-requisite for the liberalisation of the aviation industry and a new regional open skies policy.
After a surge in uptake during the Covid-19 pandemic, the telehealth industry is courting new investment to further innovation and increase access to care in emerging markets.
The Turkish Prime Minister Bulent Ecevit has spent the last week in the US hoping to garner support for economic reforms at home and trade concessions for Turkish exports to the US.
